Renal therapy using tissue-engineered constructs and gene delivery

World Journal of Urology

Volumn 18, Issue 1, 2000, Pages 71-79

  Amid, Gilad E ^a   Yoo, James J ^a   Atala, Anthony ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL;

ARTIFICIAL KIDNEY; BIOMEDICAL ENGINEERING; CHRONIC KIDNEY FAILURE; GENE THERAPY; HUMAN; KIDNEY TRANSPLANTATION; METHODOLOGY; RENAL REPLACEMENT THERAPY; REVIEW;

BIOCOMPATIBLE MATERIALS; BIOMEDICAL ENGINEERING; GENE THERAPY; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; KIDNEY, ARTIFICIAL; RENAL DIALYSIS;

EID: 0034137293     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003450050013     Document Type: Article

References (63)

1. Atala A, Vacanti JP, Peters CA, Mandell J, Retik AB, et al (1992) Formation of urothelial structures in vivo from dissociated cells attached to biodegradable polymer scaffolds in vitro. J Urol 148: 658-662
2. Atala A, Freeman MR, Vacanti JP, Shepard J, Retik AB (1993) Implantation in vivo and retrieval of artificial structures consisting of rabbit and human urothelium and human bladder muscle. J Urol 150: 608-612
3. Atala A, Schlüssel RN, Retik AB (1995) Renal cell growth in vivo after attachment to biodegradable polymer scaffolds. J Urol 153: 4
4. Bailie G, Rocco MF, et al (1997) Peritoneal Dialysis Core Indicators Study (PD-CIS): hematocrit (Hct) and blood pressure (BP) data (abstract). J Am Soc Nephrol 8: 215A
5. Bloembergen WE, Port FK (1996) Epidemiological prospectives on infections in chronic dialysis patients. Adv Renal Replace Ther 3: 201-207
6. Border WA, Noble NA (1993) Cytokines in kidney disease: the role of transforming growth factor-beta. Am J Kidney Dis 22: 105-113
7. Brezis M, Rosen S (1995) Hypoxia of the renal medula - its implications for disease. N Engl J Med 332: 647-655
8. Carley WW, Milici AJ, Madri JA (1988) Extracellular matrix specificity for the differentiation of capillary endothelial cells. Exp Cell Res 178: 426-434
9. Chazan JA, Libbey NP, London MR, et al (1991) The clinical spectrum of renal osteodystrophy in 57 hemodialysis patients: a correlation between biochemical parameters and bone pathology findings. Clin Nephrol 35: 78-85
10. Cohen J, Hopkin J, Kurtz J (1994) Infectious complications after renal transplantation. In: Morris PJ (ed) Kidney transplantation: principles and practice. Saunders, Philadelphia pp 364-389
11. Feldman HI, Kobrin S, Wasserstein A (1996) Hemodialysis vascular access morbidity. J Am Soc Nephrol 7: 523-535
12. Folkman J, Hochberg MM (1973) Self-regulation of growth in three dimensions. J Exp Med 138: 745-749
13. Frank J, Engler-Blum G, Rodemann HP, et al (1993) Human renal tubular cells as a cytokine source: PDGF-B, GM-CSF and IL-6 mRNA expression in vitro. Exp Nephrol 1: 26-35
14. Freed LE, Vunjak-Novakovic G, Biron RJ, Eagles DB, Lesnoy DC, Barlow SK, Langer R (1994) Biodegradable polymer scaffolds for tissue engineering. Bio/Technology 12: 689-693
15. Fung LCT, Elenius K, Freeman M, Donovan MJ, Atala A (1996) Reconstitution of EGFr-poor renal epithelial cells into tubular structures on biodegradable polymer scaffold. Pediatrics 98 [Suppl]: S631
16. Golumbek PT, Lazenby AJ, Levitzky HI, et al (1991) Treatment of establishment renal cancer by tumor cells engineered to secrete interleukin-4. Science 254: 713-716
17. Health Care Financing Administration, Department of Human Health Services (1997) End stage renal disease program highlights (fact sheet). Department of Human Health Services, Bethesda, Maryland
18. Hirokoshi S, Koide H, Shirai T (1988) Monoclonal antibodies against laminin A chain and B chain in the human and mouse kidney. Lab Invest 58: 532-538
19. Hubbel JA, Massia SP, et al (1991) Endothelial cell-selective materials for tissue engineering in the vascular graft via a new receptor. Bio/Technology 9: 568-572
20. Humes DH, Ceileski DA (1992) Interaction between growth factors and retinoic acid in the induction of key tubulogenesis in tissue culture. Exp Cell Res 201: 8-15
21. Humes DH, Ceileski DA, Funke AJ (1995) Cell therapy for erythropoietin (EPO) deficient anemias (abstract). J Am Soc Nephrol 6: 535
22. Humes DH, Buffington DA, MacKay SM, Funke AJ, Weitzel WF (1999) Replacement of renal function in uremic animals with a tissue engineered kidney. Nat Biotechnol 17: 451-455
23. Julian BA, Benfield M, Quarles LD (1993) Bone loss after organ transplantation. Transplant Rev 7: 82-95
24. Kasiske BL (1998) The evaluation of prospective renal transplant recipients and living donors. Surg Clin North Am 78: 27-39
25. Kelly KJ, Williams WWJ, Colvin RB, et al (1994) Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury. Proc Natl Acad Sei USA 91: 812-816
26. Kitamura M, Taylor S, Shimizu F, Fine LG (1993) Gene transfer into the glomerulus via a mesengial cell vector. Proceedings, American Society of Nephrology Meeting, Boston, Massachusetts, 14-17 November 1993
27. Kropp BP, Rippy MK, Badylak SF, et al (1996) Regenerative urinary bladder augmentation using small intestinal submucosa: urodynamic and histopathologic assessment in long-term canine bladder augmentation. J Urol 155: 2098-2104
28. Locatelli F, Pontoriero G, Di Filippo S (1998) Electrolyte disorders and substitution fluid in continuous renal replacement therapy. Kidney Int 66 [Suppl]: S151-S155
29. Lyerly HK, DiMaio JM (1993) Gene delivery systems in surgery. Arch Surg 128: 1197-1201
30. Maack T (1992) Renal handling of proteins and polypeptides. In: Windhager EE (ed) Handbook of physiology. Oxford University, New York, pp 2039-2118
31. MacKay SM, Funke AJ, Buffington DA, Humes DH (1998) Tissue engineering of a bioartificial tubule. ASAIO J 44: 179-183
32. Manns M, Sigler MH, Teehan BP (1998) Continuous renal replacement therapies: an update. Am J Kidney Dis 32: 185-207
33. Mikos AG, Sarakinos G, Lyman MD, et al (1993) Prevascularization of porous biodegradable polymers. Biotechnol Bioeng 42: 716-723
34. Milici AJ, Furie MB, Carley WW (1985) The formation of fenestrations and channels by capillary endothelium in vitro. Proc Natl Acad Sci USA 82: 6181-6185
35. Mooney DJ, Organ G, Vacanti JP, Langer R (1994) Design and fabrication of biodegradable polymer devices to engineer tubular tissues. Cell Transplant 3: 438-4146
36. Mooney DJ, Park S, Kaufmann PM, Sano S, McNamara K, Vacanti JP, Langer R (1995) Biodegradable sponges for hepatocyte transplantation. J Biomed Mater Res 29: 959-966
37. Mooney DJ, Breuer C, Mcnamara K, et al (1996) Fabricating tubular devices from polymers of lactic and glycolic acid for tissue engineering. Tissue Eng 1: 107-118
38. Mooney DJ, Mazzoni CL, Breuer C, Mcnamara K, Hern D, Vacanti JP, Langer R (1996) Stabilized polyglycolic acid fiber-based devices for tissue engineering. Biomaterials 17: 115-124
39. Mulligan RC (1993) The basic science of gene therapy. Science 260: 926-930
40. Murray JE, Merrill JP, Harrison JH (1955) Renal homotransplantation in identical twins. Surg Forum 6: 432-4436
41. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (1997) United States renal data system. Annual data report. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland
42. Nikolovski J, Poirier S, Funke AJ, et al (1996) Development of a bioartificial renal tubule for the treatment of acute renal failure (abstract). J Am Soc Nephrol 7: 1376
43. Nolph KD (1996) Peritoneal dialysis. In: Gonick HC (ed) Current nephrology, vol 19. Mosby-YearBook, St. Louis, pp 281-282
44. Onishi S, Andress DL, Maloney NA, et al (1991) Beta-2-microglobulin deposition in bone in chronic renal failure. Kidney Int 39: 990-995
45. Raine AEG (1994) Cardiovascular complications after renal transplantation. In: Morris PJ (eds) Kidney transplantation: principles and practice. Saunders, Philadelphia, pp 339-355
46. Revillard JP, Vincent C (1988) Structure and metabolism of beta-2-microglobulin. Contrib Nephrol 62: 44-53
47. Rocco MV, Bleyer AJ, Burkart JM (1996) Utilization of inpatient and outpatient resources for the management of hemodialysis access complications. Am J Kidney Dis 28: 250-256
48. Schena FP (1998) Role of growth factors in acute renal failure. Kidney Int 53 [Suppl]: S11-S15
49. Sessa A, Ghiggeri GM, Turco AE (1997) Autosomal dominant polycystic kidney disease: clinical and genetic aspects. J Nephrol 10: 295-310
50. Stadnyk AW (1994) Cytokine production by epithelial cells. FASEB J 8: 1041-1047
51. Sukhatme VP (1995) Prospects for gene therapy in the kidney. In: Schlondorff DBJ (ed) Molecular nephrology- kidney function in health and disease: Marcel Dekker, Basel, pp 913-921
52. Tachibana M, Nagamatsu GR, Addonizio JC (1985) Ureteral replacement using collagen tube sponge grafts. J Urol 133: 866-869
53. Tomita N, Higaki J, Morishita R, et al (1992) Directed in vivo gene introduction into rat kidney. Biochem Biophys Res Commun 186: 129-134
54. United Network for Organ Sharing (1996) People awaiting transplants. United Network for Organ Sharing. Richmond, Virginia
55. United States Renal Data System (USRDS) (1996) USRDS Dialysis Morbidity and Mortality Study, wave 1. Annual data report. USRDS, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland
56. Vilingo G, Colombo A, Scalamogna A, et al (1989) Prospective randomized study of two Y devices in continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 9: 165-168
57. White RA, Hirose FM, Sproat RW, et al (1981) Histologic observations after short-term implantation of two porous elastomers in dogs. Biomaterials 2: 171-176
58. Wilson JM, Birinyi LK, Salomon RN, et al (1989) Implantation of vascular grafts lined with genetically modified endothelial cells. Science 244: 1344-1346
59. Woods JD, Humes DH (1997) Prospects for a bioartificial kidney. Semin Nephrol 17: 381-386
60. Yoo JJ, Atala A (1997) A novel gene delivery system using urothelial tissue engineered neo-organs. J Urol 158: 1066-1070
61. Yoo JJ, Ashkar S, Atala A (1996) Creation of functional kidney structures with excretion of kidney-like fluid in vivo. Pediatrics 98 [Suppl]: S605
62. Yoo JJ, Soker S, Lin LF, Mehegan K, Guthrie PD, Atala A (1999) Direct in vivo gene transfer to urological organs. J Urol 162: 1115-1118
63. Zweibel JA, Freeman SM, Kantoff PW, et al (1989) High-level recombinant gene expression in rabbit endothelial cells transduced by retroviral vectors. Science 243: 220-222